FDA NDC Directory · JSON-LD · Markdown

Bexarotene

NDC 43975-315 · HUMAN PRESCRIPTION DRUG · CAPSULE, LIQUID FILLED

Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209861
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsBEXAROTENE (75 mg/1)
Marketing started20180510
Package count1

External sources

Source: openFDA. Public-domain (CC0).